Sitagliptin Modulates Oxidative, Nitrative and Halogenative Stress and Inflammatory Response in Rat Model of Hepatic Ischemia-Reperfusion

A possibility of repurposing sitagliptin, a well-established antidiabetic drug, for alleviating injury caused by ischemia-reperfusion (IR) is being researched. The aim of this study was to shed some light on the molecular background of the protective activity of sitagliptin during hepatic IR. The ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Małgorzata Trocha (Author), Mariusz G. Fleszar (Author), Paulina Fortuna (Author), Łukasz Lewandowski (Author), Kinga Gostomska-Pampuch (Author), Tomasz Sozański (Author), Anna Merwid-Ląd (Author), Małgorzata Krzystek-Korpacka (Author)
Format: Book
Published: MDPI AG, 2021-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c0ff3ac3f08c428da84768a8f4f0f2c3
042 |a dc 
100 1 0 |a Małgorzata Trocha  |e author 
700 1 0 |a Mariusz G. Fleszar  |e author 
700 1 0 |a Paulina Fortuna  |e author 
700 1 0 |a Łukasz Lewandowski  |e author 
700 1 0 |a Kinga Gostomska-Pampuch  |e author 
700 1 0 |a Tomasz Sozański  |e author 
700 1 0 |a Anna Merwid-Ląd  |e author 
700 1 0 |a Małgorzata Krzystek-Korpacka  |e author 
245 0 0 |a Sitagliptin Modulates Oxidative, Nitrative and Halogenative Stress and Inflammatory Response in Rat Model of Hepatic Ischemia-Reperfusion 
260 |b MDPI AG,   |c 2021-07-01T00:00:00Z. 
500 |a 10.3390/antiox10081168 
500 |a 2076-3921 
520 |a A possibility of repurposing sitagliptin, a well-established antidiabetic drug, for alleviating injury caused by ischemia-reperfusion (IR) is being researched. The aim of this study was to shed some light on the molecular background of the protective activity of sitagliptin during hepatic IR. The expression and/or concentration of inflammation and oxidative stress-involved factors have been determined in rat liver homogenates using quantitative RT-PCR and Luminex<sup>®</sup> xMAP<sup>®</sup> technology and markers of nitrative and halogenative stress were quantified using targeted metabolomics (LC-MS/MS). Animals (n = 36) divided into four groups were treated with sitagliptin (5 mg/kg) (S and SIR) or saline solution (C and IR), and the livers from IR and SIR were subjected to ischemia (60 min) and reperfusion (24 h). The midkine expression (by 2.2-fold) and the free 3-nitrotyrosine (by 2.5-fold) and IL-10 (by 2-fold) concentration were significantly higher and the <i>Nox4</i> expression was lower (by 9.4-fold) in the IR than the C animals. As compared to IR, the SIR animals had a lower expression of interleukin-6 (by 4.2-fold) and midkine (by 2-fold), a lower concentration of 3-nitrotyrosine (by 2.5-fold) and a higher <i>Nox4</i> (by 2.9-fold) and 3-bromotyrosine (by 1.4-fold). In conclusion, IR disturbs the oxidative, nitrative and halogenative balance and aggravates the inflammatory response in the liver, which can be attenuated by low doses of sitagliptin. 
546 |a EN 
690 |a drug repurposing 
690 |a dipeptidylpeptidase-4 antagonists 
690 |a midkine 
690 |a bromotyrosine 
690 |a nitrotyrosine 
690 |a liver transplantation 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 10, Iss 8, p 1168 (2021) 
787 0 |n https://www.mdpi.com/2076-3921/10/8/1168 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/c0ff3ac3f08c428da84768a8f4f0f2c3  |z Connect to this object online.